Ninety-five years ago, Winston Churchill imagined a future in which people could grow chicken parts separately instead of raising whole birds. That idea now sits at the center of a fast-changing industry known as cultivated meat. Recent developments show both the promise and the practical hurdles that remain. ([1])
The 1931 Prediction
Churchill wrote the essay “Fifty Years Hence” while out of power and earning money through freelance writing. He described a process that would let producers grow specific cuts, such as a breast or wing, under controlled conditions rather than raising an entire animal. The passage captured an early vision of what scientists would later attempt with cell culture techniques.
That vision resurfaced in the 2010s when venture capital began funding startups that harvest stem cells from living animals and grow them in bioreactors. The approach aimed to produce meat without the full cycle of conventional livestock farming. Interest peaked between 2021 and 2023, when companies raised more than $2.5 billion.
Funding Surge Followed by Closures
Early backers included traditional venture firms, sovereign wealth funds, and even major meat processors such as Tyson Foods and JBS. Several startups reached high valuations and built large facilities. Believer Meats, for example, completed a 200,000-square-foot plant in North Carolina before losing key financing.
By late 2025 the picture had shifted. Meatable, CellRev, and Upstream Foods all ceased operations after failing to secure additional capital or meet commercial targets. Believer Meats, once valued at $600 million, shut down before any product reached the market. Investors cited long development timelines and high capital costs as reasons for pulling back.
Regulatory Approvals and Market Limits
Regulators in several countries have cleared specific cultivated products. The U.S. Food and Drug Administration and the USDA’s Food Safety and Inspection Service approved cultured chicken, pork, and salmon from five companies between 2023 and 2025. Singapore granted the first approval in 2020. Yet broad retail availability has not followed.
Manufacturers continue to work on scaling production to lower costs. The FDA has noted that consistent large-volume output at competitive prices remains the main barrier. In the meantime, more than twenty states have passed labeling rules or outright restrictions on cultivated meat to protect conventional livestock producers and address consumer questions about the technology.
State Restrictions and Industry Response
Alabama, Florida, Mississippi, Montana, and Nebraska enacted bans or criminal penalties on the manufacture and sale of cultivated meat. Indiana and Texas imposed temporary limits extending into 2027. South Dakota began a five-year moratorium in July 2026 that also restricts state funding for related research.
Technology companies argue these measures limit innovation and consumer choice. Traditional agriculture interests counter that the rules protect ranchers and ensure transparency. The European Food Safety Authority has not yet approved any cell-cultured animal products for sale in the European Union.
Practical Trade-offs
Proponents highlight potential gains in animal welfare, reduced land and water use, and lower risk of foodborne pathogens. Production occurs in sterile environments that avoid many of the contamination routes found in conventional supply chains. Some developers also explore ways to adjust nutrient profiles during growth.
Critics point to high energy demands, expensive nutrient media, and consumer skepticism about products viewed as highly processed. Replicating the texture of whole cuts such as steaks remains technically difficult. Early reliance on animal-derived growth factors in some processes has raised additional ethical questions.
What matters now: Cultivated meat has moved from laboratory proof of concept to limited regulatory clearance, yet commercial scale and consumer acceptance are still years away. State-level restrictions and funding realities will shape how quickly the sector can expand.
More than a decade after the first cultivated burger was presented publicly, the technology has not reached everyday grocery shelves. The coming years will show whether the industry can overcome cost and scale challenges or whether regulatory and market pressures keep it on the margins.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.